DE68919649T2 - Kombinationen von sympathomimetika mit beta-1 selektiven betablockern enthaltende mittel gegen glaucoma. - Google Patents

Kombinationen von sympathomimetika mit beta-1 selektiven betablockern enthaltende mittel gegen glaucoma.

Info

Publication number
DE68919649T2
DE68919649T2 DE68919649T DE68919649T DE68919649T2 DE 68919649 T2 DE68919649 T2 DE 68919649T2 DE 68919649 T DE68919649 T DE 68919649T DE 68919649 T DE68919649 T DE 68919649T DE 68919649 T2 DE68919649 T2 DE 68919649T2
Authority
DE
Germany
Prior art keywords
beta
selective
betablockers
sympathomimetics
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68919649T
Other languages
English (en)
Other versions
DE68919649D1 (de
Inventor
Santis Louis De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22684861&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE68919649(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Application granted granted Critical
Publication of DE68919649D1 publication Critical patent/DE68919649D1/de
Publication of DE68919649T2 publication Critical patent/DE68919649T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE68919649T 1988-04-26 1989-04-26 Kombinationen von sympathomimetika mit beta-1 selektiven betablockern enthaltende mittel gegen glaucoma. Expired - Fee Related DE68919649T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18641588A 1988-04-26 1988-04-26
PCT/US1989/001748 WO1989010120A1 (en) 1988-04-26 1989-04-26 Antiglaucoma compositions containing combinations of sympathomimetic agents and beta-1 selective beta-blockers

Publications (2)

Publication Number Publication Date
DE68919649D1 DE68919649D1 (de) 1995-01-12
DE68919649T2 true DE68919649T2 (de) 1995-04-06

Family

ID=22684861

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68919649T Expired - Fee Related DE68919649T2 (de) 1988-04-26 1989-04-26 Kombinationen von sympathomimetika mit beta-1 selektiven betablockern enthaltende mittel gegen glaucoma.

Country Status (9)

Country Link
EP (1) EP0366765B1 (de)
JP (1) JPH02504150A (de)
KR (1) KR0124465B1 (de)
AT (1) ATE114461T1 (de)
AU (1) AU617479B2 (de)
CA (1) CA1338519C (de)
DE (1) DE68919649T2 (de)
DK (1) DK645489A (de)
WO (1) WO1989010120A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4201079C3 (de) * 1992-01-17 1997-09-11 Gramer Eugen Kombinationspräparate zur Augeninnendrucksenkung
EP0582321A1 (de) * 1992-01-17 1994-02-09 Gramer, Eugen, Prof.Dr.med.Dr.jur. Kombinationspräparat auf der Basis von Dipivalylepinephrin (DPE) und Betablocker zur Augeninnendrucksenkung
US6015837A (en) * 1996-08-29 2000-01-18 New York Medical College Method for treating scoliosis with β2-adrenoceptor agonists
EP1781331A1 (de) * 2004-08-09 2007-05-09 Université Catholique de Louvain Verwendung von agonisten und antagonisten von beta-adrenozeptoren zur behandlung von arterienerkrankungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852468A (en) * 1967-02-27 1974-12-03 Ici Ltd Alkanolamine derivatives as {62 -adrenergic blocking agents

Also Published As

Publication number Publication date
AU617479B2 (en) 1991-11-28
CA1338519C (en) 1996-08-13
WO1989010120A1 (en) 1989-11-02
DK645489D0 (da) 1989-12-19
EP0366765A4 (en) 1990-12-05
AU3555989A (en) 1989-11-24
EP0366765B1 (de) 1994-11-30
ATE114461T1 (de) 1994-12-15
DK645489A (da) 1989-12-19
KR900700090A (ko) 1990-08-11
EP0366765A1 (de) 1990-05-09
JPH02504150A (ja) 1990-11-29
DE68919649D1 (de) 1995-01-12
KR0124465B1 (ko) 1997-11-25

Similar Documents

Publication Publication Date Title
AU4515296A (en) A method for enhancing outflow of aqueous humor in treatment of glaucoma
IE811654L (en) Ophthalmic composition
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
SE8403090L (sv) Gel for anvendning som glaskroppssubstitut
ES2042625T3 (es) Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
AU2307999A (en) Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
AU1745388A (en) Thiophene sulfonamide antiglaucoma agents
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
DE68919649D1 (de) Kombinationen von sympathomimetika mit beta-1 selektiven betablockern enthaltende mittel gegen glaucoma.
RU97120710A (ru) Способ увеличения скорости кровотока глазного нерва и сетчатки глаза
EP0403360A3 (de) Verwendung von Phenylethanolaminen zur Herstellung von Medikamenten gegen Augenleiden
WO1990009187A1 (en) Eye drops for healing wound of corneal epithelium
DE3273950D1 (en) Use of 1-(p-isopropoxyethoxymethyl-phenoxy)-3-isopropylaminopropan-2-ol for the preparation of a medicament for the reduction of internal pressure in the eye
ATE117208T1 (de) Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
ES2118941T3 (es) Composiciones antiglaucoma topicas que comprenden inhibidores de anhidrasa carbonica y bloqueantes beta.
EP0345028A3 (de) Verwendung eines Phosphodiesterase-Inhibitors zur Glaukombehandlung
DE3688503T2 (de) Erhöhung des ausfliessens wässriger körperfluessigkeit.
EP0227416A3 (de) Dopamin-Agoniste zur Behandlung von erhöhtem intraokularem Druck
Cebon et al. Experience with dipivalyl epinephrine: its effectiveness, alone or in combination, and its side effects
RU94035530A (ru) Способ антиглаукоматозной операции
BG60887B1 (en) Thienethiopyran sulphonamide derivatives and their application in ophthalmological preparations
RU96110996A (ru) Способ формирования доступа при операциях на перилимбальной зоне склеры
RU97104139A (ru) Способ лечения отслойки сетчатки с отрывом
RU93043496A (ru) Средство антиоксидантной защиты сред и тканей глаза
RU97122337A (ru) Способ лечения открытоугольной глаукомы

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee